001package org.hl7.fhir.dstu3.model.codesystems;
002
003
004
005
006/*
007  Copyright (c) 2011+, HL7, Inc.
008  All rights reserved.
009  
010  Redistribution and use in source and binary forms, with or without modification, 
011  are permitted provided that the following conditions are met:
012  
013   * Redistributions of source code must retain the above copyright notice, this 
014     list of conditions and the following disclaimer.
015   * Redistributions in binary form must reproduce the above copyright notice, 
016     this list of conditions and the following disclaimer in the documentation 
017     and/or other materials provided with the distribution.
018   * Neither the name of HL7 nor the names of its contributors may be used to 
019     endorse or promote products derived from this software without specific 
020     prior written permission.
021  
022  THIS SOFTWARE IS PROVIDED BY THE COPYRIGHT HOLDERS AND CONTRIBUTORS "AS IS" AND 
023  ANY EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED 
024  WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE ARE DISCLAIMED. 
025  IN NO EVENT SHALL THE COPYRIGHT HOLDER OR CONTRIBUTORS BE LIABLE FOR ANY DIRECT, 
026  INDIRECT, INCIDENTAL, SPECIAL, EXEMPLARY, OR CONSEQUENTIAL DAMAGES (INCLUDING, BUT 
027  NOT LIMITED TO, PROCUREMENT OF SUBSTITUTE GOODS OR SERVICES; LOSS OF USE, DATA, OR 
028  PROFITS; OR BUSINESS INTERRUPTION) HOWEVER CAUSED AND ON ANY THEORY OF LIABILITY, 
029  WHETHER IN CONTRACT, STRICT LIABILITY, OR TORT (INCLUDING NEGLIGENCE OR OTHERWISE) 
030  ARISING IN ANY WAY OUT OF THE USE OF THIS SOFTWARE, EVEN IF ADVISED OF THE 
031  POSSIBILITY OF SUCH DAMAGE.
032  
033*/
034
035// Generated on Sat, Mar 25, 2017 21:03-0400 for FHIR v3.0.0
036
037
038import org.hl7.fhir.exceptions.FHIRException;
039
040public enum V3SubstanceAdminSubstitution {
041
042        /**
043         * Description: Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects.
044         */
045        _ACTSUBSTANCEADMINSUBSTITUTIONCODE, 
046        /**
047         * Description: Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.
048         */
049        E, 
050        /**
051         * Description: 
052                        
053
054                        Substitution occurred or is permitted with another product that is a:
055
056                        
057                           pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester
058                           pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration
059                        
060                        
061                           Examples: 
062                        
063
064                        
065                           
066                              Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate
067                           
068                              Pharmaceutical equivalent: Lisonpril for Zestril
069         */
070        EC, 
071        /**
072         * Description: 
073                        
074
075                        Substitution occurred or is permitted between equivalent Brands but not Generics
076
077                        
078                           Examples: 
079                        
080
081                        
082                           Zestril  for Prinivil
083                           Coumadin for Jantoven
084         */
085        BC, 
086        /**
087         * Description: Substitution occurred or is permitted between equivalent Generics but not Brands
088
089                        
090                           Examples: 
091                        
092
093                        
094                           Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)
095         */
096        G, 
097        /**
098         * Description: Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile.
099
100                        
101                           Examples: 
102                        
103
104                        
105                           ranitidine for Tagamet
106         */
107        TE, 
108        /**
109         * Description: Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics
110>
111                           Examples: 
112                        
113
114                        
115                           Zantac for Tagamet
116         */
117        TB, 
118        /**
119         * Description: Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands
120>
121                           Examples: 
122                        
123
124                        
125                           Ranitidine  for cimetidine
126         */
127        TG, 
128        /**
129         * Description: This substitution was performed or is permitted based on formulary guidelines.
130         */
131        F, 
132        /**
133         * No substitution occurred or is permitted.
134         */
135        N, 
136        /**
137         * added to help the parsers
138         */
139        NULL;
140        public static V3SubstanceAdminSubstitution fromCode(String codeString) throws FHIRException {
141            if (codeString == null || "".equals(codeString))
142                return null;
143        if ("_ActSubstanceAdminSubstitutionCode".equals(codeString))
144          return _ACTSUBSTANCEADMINSUBSTITUTIONCODE;
145        if ("E".equals(codeString))
146          return E;
147        if ("EC".equals(codeString))
148          return EC;
149        if ("BC".equals(codeString))
150          return BC;
151        if ("G".equals(codeString))
152          return G;
153        if ("TE".equals(codeString))
154          return TE;
155        if ("TB".equals(codeString))
156          return TB;
157        if ("TG".equals(codeString))
158          return TG;
159        if ("F".equals(codeString))
160          return F;
161        if ("N".equals(codeString))
162          return N;
163        throw new FHIRException("Unknown V3SubstanceAdminSubstitution code '"+codeString+"'");
164        }
165        public String toCode() {
166          switch (this) {
167            case _ACTSUBSTANCEADMINSUBSTITUTIONCODE: return "_ActSubstanceAdminSubstitutionCode";
168            case E: return "E";
169            case EC: return "EC";
170            case BC: return "BC";
171            case G: return "G";
172            case TE: return "TE";
173            case TB: return "TB";
174            case TG: return "TG";
175            case F: return "F";
176            case N: return "N";
177            case NULL: return null;
178            default: return "?";
179          }
180        }
181        public String getSystem() {
182          return "http://hl7.org/fhir/v3/substanceAdminSubstitution";
183        }
184        public String getDefinition() {
185          switch (this) {
186            case _ACTSUBSTANCEADMINSUBSTITUTIONCODE: return "Description: Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects.";
187            case E: return "Description: Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.";
188            case EC: return "Description: \n                        \r\n\n                        Substitution occurred or is permitted with another product that is a:\r\n\n                        \n                           pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester\n                           pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration\n                        \n                        \n                           Examples: \n                        \r\n\n                        \n                           \n                              Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate\n                           \n                              Pharmaceutical equivalent: Lisonpril for Zestril";
189            case BC: return "Description: \n                        \r\n\n                        Substitution occurred or is permitted between equivalent Brands but not Generics\r\n\n                        \n                           Examples: \n                        \r\n\n                        \n                           Zestril  for Prinivil\n                           Coumadin for Jantoven";
190            case G: return "Description: Substitution occurred or is permitted between equivalent Generics but not Brands\r\n\n                        \n                           Examples: \n                        \r\n\n                        \n                           Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)";
191            case TE: return "Description: Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile.\r\n\n                        \n                           Examples: \n                        \r\n\n                        \n                           ranitidine for Tagamet";
192            case TB: return "Description: Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics\r\n>\n                           Examples: \n                        \r\n\n                        \n                           Zantac for Tagamet";
193            case TG: return "Description: Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands\r\n>\n                           Examples: \n                        \r\n\n                        \n                           Ranitidine  for cimetidine";
194            case F: return "Description: This substitution was performed or is permitted based on formulary guidelines.";
195            case N: return "No substitution occurred or is permitted.";
196            case NULL: return null;
197            default: return "?";
198          }
199        }
200        public String getDisplay() {
201          switch (this) {
202            case _ACTSUBSTANCEADMINSUBSTITUTIONCODE: return "ActSubstanceAdminSubstitutionCode";
203            case E: return "equivalent";
204            case EC: return "equivalent composition";
205            case BC: return "brand composition";
206            case G: return "generic composition";
207            case TE: return "therapeutic alternative";
208            case TB: return "therapeutic brand";
209            case TG: return "therapeutic generic";
210            case F: return "formulary";
211            case N: return "none";
212            case NULL: return null;
213            default: return "?";
214          }
215    }
216
217
218}